Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

4 recruiting2 with results

Enrollment Performance

Analytics

Early Phase 1
4(57.1%)
Phase 1
2(28.6%)
N/A
1(14.3%)
7Total
Early Phase 1(4)
Phase 1(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07294092Early Phase 1Recruiting

Ketamine and Propofol NeuroImaging

Role: lead

NCT06702631Early Phase 1Recruiting

Nitrous Oxide Neuroimaging

Role: lead

NCT06044740Early Phase 1Completed

Sevoflurane's Effect on Neurocognition Study

Role: lead

NCT07290205Early Phase 1Recruiting

Remimazolam NeuroImaging

Role: lead

NCT06825390Not ApplicableRecruiting

AuriculoTherapy NeuroImaging

Role: lead

NCT04062123Phase 1Completed

Memory & Conditioning Under Anesthesia

Role: lead

NCT05501600Phase 1Completed

Neural Correlates of Lidocaine Analgesia

Role: lead

All 7 trials loaded